Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 22
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 2024 Fassan M.Zulato E. + ONCOLOGY AND THERAPY - -
EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience 2022 Dal Maso, ADel Bianco, PNardo, GZulato, EBonanno, LPasello, GIndraccolo, S + JOURNAL OF THORACIC DISEASE - -
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? 2022 Bonanno, LauraDal Maso, AlessandroZulato, ElisabettaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, Stefano + BRITISH JOURNAL OF CANCER - -
Implementation of next generation sequencing-based liquid biopsy for clinical molecular diagnostics in non-small cell lung cancer (Nsclc) patients 2021 Zulato E.Tosello V.Nardo G.Bonanno L.Del Bianco P.Indraccolo S. DIAGNOSTICS - -
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 2021 Boscolo Bragadin, AndreaZulato, ElisabettaAttili, IlariaDal Maso, AlessandroFrega, StefanoFassan, MatteoCalabrese, FiorellaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, StefanoBonanno, Laura + TRANSLATIONAL LUNG CANCER RESEARCH - -
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 2021 Urso L.Vernaci G.Fassan M.Zulato E.Faggioni G.Menichetti A.Di Liso E.Griguolo G.Conte P.Indraccolo S.Guarneri V.Dieci M. V. + FRONTIERS IN ONCOLOGY - -
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors 2021 Marra, LudovicaBonanno, LauraBoscolo, AliceDal Maso, AlessandroBoscolo Bragadin, AndreaIndraccolo, StefanoZulato, Elisabetta + FRONTIERS IN ONCOLOGY - -
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features 2021 Bonanno, L.Dal Maso, A.Zulato, E.Fassan, M.Pasello, G.Guarneri, V.Calabrese, F.Rea, F.Indraccolo, S.Conte, P. F. + JOURNAL OF THORACIC ONCOLOGY - -
Detection of loss of heterozygosity in cfDNA of advanced EGFR-or KRAS-mutated non-small-cell lung cancer patients 2020 Nardo G.Zulato E.Bonanno L.Frega S.Indraccolo S. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer 2020 Zulato, ElisabettaAttili, IlariaPavan, AlbertoDel Bianco, PaolaBoscolo Bragadin, AndreaPasello, GiuliaFassan, MatteoCalabrese, FiorellaGuarneri, ValentinaAmadori, AlbertoConte, PierFrancoIndraccolo, StefanoBonanno, Laura + BRITISH JOURNAL OF CANCER - -
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach 2020 Piga I.Montenegro F.Nardo G.Zulato E.Del Bianco P.Indraccolo S. + FRONTIERS IN ONCOLOGY - -
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 2020 Zulato, ElisabettaFerro, AlessandraBoscolo, AliceAttili, IlariaFrega, StefanoDal Maso, AlessandroPasello, GiuliaGuarneri, ValentinaConte, Pier FrancoIndraccolo, StefanoBonanno, Laura + JOURNAL OF CLINICAL ONCOLOGY - -
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective 2019 Ciccarese F.Zulato E.Indraccolo S. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY - -
Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy 2019 Bonanno, L.Zulato, E.Attili, I.Del Bianco, P.Nardo, G.Boscolo Bragadin, A.Pasqualini, L.Calabrese, F.Fassan, M.Pasello, G.Guarneri, V.Conte, P.Indraccolo, S. + ANNALS OF ONCOLOGY - -
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 2019 Pasello, GiuliaDal Maso, AlessandroLorenzi, MartinaScattolin, DanielaUrso, LoredanaZulato, ElisabettaFrega, StefanoBonanno, LauraIndraccolo, StefanoCalabrese, FiorellaConte, Pierfranco + JOURNAL OF CLINICAL ONCOLOGY - -
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC 2018 Zulato E.Indraccolo S. + JOURNAL OF THORACIC ONCOLOGY - -
Involvement of NADPH Oxidase 1 in Liver Kinase B1-mediated effects on tumor angiogenesis and growth 2018 Elisabetta ZulatoFrancesco CiccareseMarica PinazzaValentina AgnusdeiMicol Silic-BenussiVincenzo CiminaleStefano Indraccolo + FRONTIERS IN ONCOLOGY - -
Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by diverse growth factors 2017 TRENTI, ANNALISAZULATO, ELISABETTAINDRACCOLO, STEFANOBOLEGO, CHIARATREVISI, LUCIA + BRITISH JOURNAL OF PHARMACOLOGY - -
LKB1 expression correlates with increased survival in advanced non-small cell lung cancer patients treated with chemotherapy and bevacizumab 2017 Bonanno, LauraDe Paoli, AngelaZulato, ElisabettaCALABRESE, FIORELLAFavaretto, AdolfoSanto, AntonioCICCARESE, FRANCESCOBertorelle, RobertaDe Salvo, Gian LucaAMADORI, ALBERTOConte, PierfrancoIndraccolo, Stefano + CLINICAL CANCER RESEARCH - -
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: Predictive value of DNA-PK and phosphorylated ACC 2016 Perrone F.Baldassarre G.Indraccolo S.Sonego M.Zulato E.Scollo P. + ONCOTARGET - -
Mostrati risultati da 1 a 20 di 22
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile